Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by Kirtapmlaon Sep 18, 2017 5:28am
190 Views
Post# 26707682

RE:Deal before end of year?

RE:Deal before end of year?

Have you ever tried to contact them instead of speculating? The best way of getting information is to pick up the phone and call the management or the IR firm. Even though they can't give away confidential information you can at least get a sense of where we are at the moment. 

They will release an update of the rest of pipeline shortly. What I have heard there is a lot of promising results on Keloid Scar. 

I believe we are on the finish line of finally getting the deal. There have been several interested parties involved therefore the extra delay. This is vital for Sirona to be able to get a good deal as possible with several parties bidding on the deal instead of only having one interested party.  

Best scenario would, of course, be if one of these companies just buy us out but that might be too much to hope for. I know many of us are frustrated and the wait has been too long with miserable communication to us shareholders. Hopefully, we will soon be all rewarded. 

I think we have a deal within a month from now. I have thought this earlier but this time many things feel right. 

 

 

Bullboard Posts